Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Bachert, C; Han, JK; Desrosiers, M; Hellings, PW; Amin, N; Lee, SE; Mullol, J; Greos, LS; Bosso, JV; Laidlaw, TM; Cervin, AU; Maspero, JF; Hopkins, C; Olze, H; Canonica, GW; Paggiaro, P; Cho, SH; Fokkens, WJ; Fujieda, S; Zhang, M; Lu, X; Fan, CP; Dra

Bachert, C (reprint author), Univ Ghent, Upper Airways Res Lab, B-9000 Ghent, Belgium.

LANCET, 2019; 394 (10209): 1638

Abstract

Background Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) generally have a high symptom burden and poor health-related quality of lif......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索